Particle.news
Download on the App Store
9 ARTICLES
·
3w ago

HHS Pulls Funding From 22 mRNA Vaccine Programs

Kennedy says mRNA vaccines underperform against respiratory infections to justify redirecting funding toward broader, more established platforms.

El Departamento de Salud y Servicios Humanos de EEUU anunció la cancelación de 22 contratos para el desarrollo de vacunas de ARNm.
El presidente de Estados Unidos, Donald Trump, escucha al secretario de Salud y Servicios Humanos, Robert F. Kennedy Jr.
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. listens at a Make Oklahoma Healthy Again kickoff event at the Oklahoma State Capitol in Oklahoma City, Oklahoma, U.S. June 26, 2025. REUTERS/Nick Oxford
Empty vials of the Pfizer-BioNTech and Moderna vaccine are pictured in a vaccination center as part of the coronavirus disease (COVID-19) vaccination campaign in Geneva, Switzerland February 3, 2021. REUTERS/Denis Balibouse cesto tacho de basura vacunas

Overview

  • HHS rescinded funding for 22 BARDA-supported mRNA vaccine projects totaling about $500 million across major pharmaceutical and academic partners.
  • Kennedy said data show mRNA vaccines do not effectively protect against upper respiratory infections such as COVID-19 and influenza.
  • Some late-stage mRNA programs will remain funded to preserve previous investments and avoid waste of taxpayer dollars.
  • Redirected resources will support vaccine platforms with established safety records and transparent clinical and manufacturing data.
  • Former BARDA director Rick Bright and other scientists warn the decision could weaken U.S. preparedness for future pandemics.